Cargando…
In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection
Coronavirus disease 2019 (COVID-19) is a highly transmissible viral infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clinical trials have reported improved outcomes resulting from an effective reduction or absence of viral load when patients were treated with chloroq...
Autores principales: | Braz, Helyson Lucas Bezerra, Silveira, João Alison de Moraes, Marinho, Aline Diogo, de Moraes, Maria Elisabete Amaral, Moraes Filho, Manoel Odorico de, Monteiro, Helena Serra Azul, Jorge, Roberta Jeane Bezerra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd and International Society of Antimicrobial Chemotherapy.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390782/ https://www.ncbi.nlm.nih.gov/pubmed/32738306 http://dx.doi.org/10.1016/j.ijantimicag.2020.106119 |
Ejemplares similares
-
Can use of hydroxychloroquine and azithromycin as a treatment of COVID-19 affect aquatic wildlife? A study conducted with neotropical tadpole
por: da Luz, Thiarlen Marinho, et al.
Publicado: (2021) -
Environmental impacts of COVID-19 treatment: Toxicological evaluation of azithromycin and hydroxychloroquine in adult zebrafish
por: Mendonça-Gomes, Juliana Moreira, et al.
Publicado: (2021) -
Hydroxychloroquine or chloroquine +/- azithromycin: heart disorders
Publicado: (2022) -
Hydroxychloroquine/chloroquine and azithromycin in COVID-19 patients: prospective study of electrical parameters
por: Ammor, Othmane, et al.
Publicado: (2021) -
Prevention and treatment of COVID-19: Focus on interferons, chloroquine/hydroxychloroquine, azithromycin, and vaccine
por: Bakadia, Bianza Moise, et al.
Publicado: (2021)